Signature,method,PMID,Definition
ADO,GSVA,31953314,Gene expression signature capturing the adenosine (ADO) pathway activity. This adenosine signature was significantly associated with reduced efficacy of anti-PD1 therapy in published cohorts.
APM_Thompson,GSVA,33028693,Gene expression signature capturing the antigen processing and presentation machinery (APM) activity. This APM signature was a predictor of the response of PD-(L)1 blockade in Lung and Melanoma patients.
APM_Wang,GSVA,31767055,Gene expression signature capturing the antigen processing and presentation machinery (APM) activity. This APM signature was a predictor of the response of PD-(L)1 blockade in published cohorts.
B_cell_Budczies,GSVA,33520406,Gene expression signature capturing the B-cells activity. This B_cell signature was a predictor of the response of PD-(L)1 blockade in Lung patients.
B_cell_Helmink,GSVA,31942075,Gene expression signature capturing the B-cells activity. This B_cell signature was a predictor of the response of ICB in published cohorts.
Blood_Response,GSVA,28807052,"Gene expression signature, derieved from whole-blood RNA-Sequencing, capturing the expression level of genes associated with response to CTLA-4 blockade."
C_ECM,weighted_mean,30410077,Gene expression signature capturing the cancer extracellular matrix (C_ECM) marker genes activity. This C_ECM signature was a predictor of the failure of PD-1 blockade and outperforms previously-proposed biomarkers.
CD8_Jiang,GSVA,30127393,Gene expression signature capturing the CD8 T cell activity. This CD8 signature was a predictor of the response of CTLA-4 and PD-1 blockade in Melanoma patients.
CD8_SF,GSVA,30388456,Gene expression signature capturing the CD8 T cell activity. This CD8 signature was a predictor of the response of ICB published cohorts.
COX_IS,specific,33220234,Gene expression signature capturing the pro-tumoral COX Inflammatory activity. This COX Inflammatory Signature (COX-IS) was a predictor of the failure of CTLA-4 and PD-(L)1 blockade in several published cohorts.
CRMA,GSVA,29656892,"Gene expression signature capturing the Cancer-Germline Antigen activity. This """"anti-CTLA-4 resistance associated MAGE-A"""" (CRMA) signature was a predictor of the failure of CTLA-4 blockade in published cohorts"
CYT,GSVA,25594174,Gene expression signature capturing the local immune cytolytic (CYT) activity. This CYT signature was a predictor of the response of ICB published cohorts
EMT_Thompson,weighted_mean,31683225,Gene expression signature capturing the epithelial-to-mesenchymal transition (EMT) activity. This EMT signature was a predictor of the failure of PD-(L)1 blockade in Lung patients
IFNG,GSVA,28650338,Gene expression signature capturing the level of IFNG. This IFNG signature was a predictor of the response of PD-1 blockade published cohorts
ImmuneCells,GSVA,33033253,Gene expression signature capturing the presence of immune cells associated with response to immunotherapy. This ImmuneCells signature was a predictor of the response of ICB published cohorts
IMPRES,weighted_mean,30127394,"Immuno-predictive score (IMPRES), a predictor of ICB response in melanoma which encompasses 15 pairwise transcriptomics relations between immune checkpoint genes. This IMPRES signature was a predictor of the response of CTLA-4 and PD-1 blockade in published cohorts"
Inflammatory,GSVA,31683225,Gene expression signature capturing the level of tumor Inflammation. This Inflammation signature was a predictor of the response of ICB published cohorts
IPRES,specific,31683225,"Gene expression signature capturing the combined epithelial-to-mesenchymal transition (EMT) and Inflammation activities. This EMT/Inflammation signature, called innate anti-PD1 resistance (IPRES) was a predictor of the failure of PD-(L)1 blockade in Lung patients"
IPS,specific,28052254,"Using machine learning, the authors identified determinants of tumor immunogenicity and developed a scoring scheme for the quantification termed immunophenoscore (IPS). This IPS signature was a predictor of the response of CTLA-4 and PD-1 in published cohorts"
IRG_Ayers,GSVA,28650338,Gene expression signature capturing the expression level of several Immune Regulatory Genes (IRG). This IRG signature was a predictor of the response of PD-1 blockade in published cohorts
IRG_Yang,weighted_mean,31741756,Gene expression signature capturing the expression level of several Immune Regulatory Genes (IRG). This IRG signature was a predictor of the response of CTLA-4 and PD-1 blockade in published cohorts
KDM5A,GSVA,32908002,Gene expression signature capturing the histone 3 lysine 4 demethylase KDM5A activity. This KDM5A signature was a predictor of the response of PD-1 blockade in published cohorts
LRRC15_CAF,GSVA,31699795,Gene expression signature capturing the presence of LRRC15+ carcinoma-associated fibroblasts (CAFs). This LRRC15_CAF signature was a predictor of the failure of PD-L1 blockade in published cohorts
M1,GSVA,31959763,Gene expression signature capturing the presenc Macrophage M1 cells. This M1 signature was a predictor of the response of PD-1 blockade in Lung patients
Macrophage,GSVA,33520406,Gene expression signature capturing the presence Macrophage cells. This Macrophage signature was a predictor of the response of ICB in Lung cohorts.
MPS,weighted_mean,32284588,Gene expression signature capturing the melanocytic plasticity (MPS) activity. This MPS signature was a predictor of the failure of CTLA-4 and PD-1 blockade in published cohorts
Myeloid_DC,GSVA,31942075,Gene expression signature capturing the myeloid dendritic cells (Myeloid_DC) activity. This Myeloid_DC signature was significantly more expressed in non-responder ICB-treated patients
NonResponse_Ivy,GSVA,32907939,The authors investigated the responsiveness of breast tumors to anti-PD-1 blockade in a mice bilateral tumor approach. They identified several genes associated with resistance to PD-1 blockade and validated there signature in published ICB cohorts
PDL1,GSVA,30127393,Gene expression signature capturing the level of PDL1. This PDL1 signature was a predictor of the response of ICB in published cohorts
peri_Tcell,GSVA,31959763,Gene expression signature capturing the presence of peripheral T cell (peri_Tcell). This peri_Tcell signature was a predictor of the response of PD-1 blockade in Lung patients
PredictIO,specific,36055464,Gene expression signature that demonstrated better and more consistent ability to predict immunotherapy response as compared to other signatures. The specific algorithm is applied to computed the signature score. The PredictIO signature was identified by integrating gene expression data from a large pan-cancer discovery immunotherapy datasets.
PTEN_MITF,weighted_mean,32245160,Gene expression signature capturing the loss of PTEN in context of MITF expression. This PTEN_MITF signature was a predictor of the failure of ICB in Melanoma patients
Response_Ivy,GSVA,32907939,The authors investigated the responsiveness of breast tumors to anti-PD-1 blockade in a mice bilateral tumor approach. They identified several genes associated with response to PD-1 blockade and validated there signature in published ICB cohorts
STAT1,GSVA,31316010;  26362649,Gene expression signature capturing the STAT1-activating cytokine interferon-_ (IFN_) activity. This STAT1 signature was a predictor of the response of ICB in published cohorts.
T_cell_exclusion,weighted_mean,30388455,Gene expression signature capturing the mechanism of T-cell exclusion. This T_cell_exclusion signature was a predictor of the failure of PD-1 blockade in Melanoma patients
T_cell_inflamed,GSVA,30804515,Gene expression signature capturing the level of Inlfamed T-cell (T_cell_inflamed). This T_cell_inflamed signature was a predictor of the response of PD-1 blockade in Melanoma patients
TGFB_Mariathasan,GSVA,29443960,Gene expression signature capturing the fibroblast TGFB activity. This TGFB signature was a predictor of the failure of PD-(L)1 blockade in published cohorts
TIS,GSVA,31684954,Gene expression signature capturing the level of local tumor inflammation. This Tumor Inflammation signature (TIS) was a predictor of the response of PD-1 blockade in pan-cancer patients
TLS,GSVA,31942071,Gene expression signature capturing the presence of Tertiary lymphoid structures (TLS). This TLS signature was a predictor of the response of ICB in Melanoma patients
12-cheomokine,specific,21703392,Gene expression signature capturing the presence of ectopic lymphoid structure. This signature was predictor of survival of colorectal cancer patients
CD274,GSVA,28650338,Gene expression signature capturing IFN-?-responsive genes. This signature was obtained from analysis of basedline sample and was a predictor of anti-PD1 response in melanoma.
T-effector,specific,29867230,Gene expression signature capturing effector T cells. This signature was a predictor of response to combination of anti-PD-L1 and sunitinib in renal cell carcinoma
T-effector_IFN_POPLAR,specific,26970723,Gene expression signature capturing effector T cells. This signature associated with improved ovarall survival of non-small-cell lung cancer patients treated with anti-PD-L1.
CD39-CD8 Tcell_Chow,specific,36574773,Gene expression signature capturing CD39+ CD8+ T cells. This signature was obtained from single-cell CITE/RNA/TCR sequencing of intratumoral CD3+ T cells from non-small cell lung cancer (NSCLC) biospecimens. This signature was a predictor of the response of anti-PD-L1 in a dataset of baseline NSCLC tumors.
VIGex,GSVA,37572657,"Gene expression signature capturing genes involved in adaptative immune response. This signature was used to score tumors are classify into hot, intermediate-cold, and cold. It associated with immunotherapy response in early-phase trials."
CIN70,specific,16921376,"Gene expression signature capturing tumor aneuploidy. This singature was predictor of poor clinical outcome in several cancer types (PMID: 16921376) and highly scored with the subtype ""cananical"" of mismatch repair-proficient coloretal liver metastases (PMID 36241710)."
